ralometostat   Click here for help

GtoPdb Ligand ID: 13320

Synonyms: TNG-908 | TNG908
PDB Ligand
Compound class: Synthetic organic
Comment: TNG908 is a small molecule competitive, reversible inhibitor of protein arginine methyltransferase 5 (PRMT5) with selectivity for PRMT5 that is in complex with methylthioadenosine (MTA) [1], a product of the enzyme methylthioadenosine phosphorylase (MTAP), that is elevated in MTAP-deleted cancers. This MTA-cooperativity is utilised to exploit the synthetic lethal relationship between PRMT5 and MTAP deletion. The outcome is significantly increased killing efficay against MTAP-null cells compared to cells expressing wild type MTAP. The physicochemical properties of TNG908 support CNS penetration.
The chemical structure of TNG908 is identical to that for the INN ralometostat (proposed list 132, Feb. 2025).
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 125.45
Molecular weight 409.51
XLogP 0.63
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H]1CC[C@H](C2=CC3=C(C=C2)SC=N3)N(C1)C(=O)C(=O)NC4=CC(=C(N)N=C4)C
Isomeric SMILES NC1=C(C=C(C=N1)NC(C(=O)N2[C@H](CC[C@@H](C2)C)C=3C=CC4=C(N=CS4)C3)=O)C
InChI InChI=1S/C21H23N5O2S/c1-12-3-5-17(14-4-6-18-16(8-14)24-11-29-18)26(10-12)21(28)20(27)25-15-7-13(2)19(22)23-9-15/h4,6-9,11-12,17H,3,5,10H2,1-2H3,(H2,22,23)(H,25,27)/t12-,17+/m0/s1
InChI Key NXXBDYHMHHINFC-YVEFUNNKSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Cottrell KM, Briggs KJ, Whittington DA, Jahic H, Ali JA, Davis CB, Gong S, Gotur D, Gu L, McCarren P et al.. (2024)
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP-Deleted Cancers.
J Med Chem, 67 (8): 6064-6080. [PMID:38595098]